Abeona Therapeutics Inc. · NASDAQ
GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOPomerantz LLP is investigating potential securities fraud claims against Abeona Therapeutics following the company's August 13, 2026 disclosure that only four of five patient treatments with ZEVASKYN were recognized for revenue due to one batch lacking minimum sheet requirements. The announcement triggered a 14.95% stock price decline.
GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEOPomerantz LLP announced investigations into potential securities fraud at Abeona Therapeutics following disclosure that only 4 of 5 ZEVASKYN treatments were recognized for revenue due to one batch lacking minimum sheet requirements. The stock fell 14.95% to $6.35 on August 13, 2026. Similar investigations were initiated for JinkoSolar and Stitch Fix.
Headlines link to the publisher. Not investment advice.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Sign in to post on $ABEO
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
